InMode Reports Fourth Quarter and Full Year 2022 Financial Results; Record Quarterly Revenue of $133.6M Represents 21% Year-Over-Year Growth
InMode Ltd. (Nasdaq: INMD) reported record financial results for Q4 and FY 2022. Q4 revenue reached $133.6 million, a 21% increase from Q4 2021, with 83% from surgical technology platforms. GAAP net income for Q4 was $37.7 million, while non-GAAP net income hit $66.4 million. For the full year, revenues reached $454.3 million, a 27% increase, with GAAP net income of $161.5 million. Looking ahead, InMode forecasts revenue between $525 million and $530 million for 2023. Investors can expect a non-GAAP EPS of $2.58 to $2.60.
- Record Q4 revenue of $133.6 million, up 21% year-over-year.
- Record non-GAAP net income of $66.4 million in Q4, up from $55.2 million.
- Full year revenue of $454.3 million, a 27% increase from 2021.
- Non-GAAP EPS of $2.42 for 2022, compared to $2.05 in 2021.
- International revenues increased by 29% year-over-year.
- GAAP net income decreased to $37.7 million in Q4 from $52.7 million a year prior.
- GAAP diluted EPS dropped to $0.44 from $0.61 in Q4 2021.
- GAAP gross margin decreased to 84% from 85% in Q4 2021.
YOKNEAM,
Fourth Quarter 2022 Highlights:
- Record quarterly revenue of
, an increase of$133.6 million 21% compared to the fourth quarter of 2021.InMode's proprietary surgical technology platforms engaged in minimally invasive and subdermal ablative treatments represented83% of quarterly revenues, while9% came fromInMode's hands-free platforms and8% fromInMode's traditional laser and non-invasive RF platforms. - GAAP net income of
, compared to$37.7 million in the fourth quarter of 2021; record *non-GAAP net income of$52.7 million , compared to$66.4 million in the fourth quarter of 2021.$55.2 million - GAAP diluted earnings per share of
, compared to$0.44 in the fourth quarter of 2021; record *non-GAAP diluted earnings per share of$0.61 , compared to$0.78 in the fourth quarter of 2021.$0.64 - Record quarterly revenues from consumables and service of
, an increase of$17.1 million 43% compared to the fourth quarter of 2021.
Full Year 2022 Highlights:
- Record full year revenues of
, an increase of$454.3 million 27% as compared to 2021;81% of revenues derived from our proprietary surgical technology platforms engaged in minimally invasive and subdermal ablative treatments,10% from our hands-free platforms and9% from our traditional laser and non-invasive RF platforms - GAAP net income of
, compared to$161.5 million in 2021; record *non-GAAP net income of$165 million , compared to$207.5 million in 2021$176.3 million - GAAP diluted earnings per share of
, compared to$1.89 in 2021; record *non-GAAP diluted earnings per share of$1.92 , compared to$2.42 in 2021$2.05 29% increase in international (non-U.S. ) revenues as compared to 2021
( | ||||
Q4 2022 | Q4 2021 | FY 2022 | FY 2021 | |
Revenues | ||||
Gross Margins | 84 % | 85 % | 84 % | 85 % |
Net Income Attributable to | ||||
Earnings per Diluted Share | ||||
*Non-GAAP Results ( | ||||
Q4 2022 | Q4 2021 | FY 2022 | FY 2021 | |
Gross Margins | 85 % | 85 % | 84 % | 85 % |
Net Income Attributable to | ||||
Earnings per Diluted Share |
*Please refer to "Use of Non-GAAP Financial Measures" below for important information about non-GAAP financial measures. Non-GAAP financial results exclude share-based compensation and certain tax adjustments. The Company applied the provisions of the amendment to the Investment Law to its exempt profits accrued prior to 2020 and made a one-time payment of
Management Comments
"We are happy to report another record revenue year and continuously high profitable growth as we scale globally and reach a yearly revenue run rate nearing
"The solid endorsement of the EmpowerRF platform significantly surpassed our most optimistic expectations for the year. Currently, we are conducting six clinical studies focusing on how this technology can positively impact a wide range of health issues for women. In addition, as we continue our strategy and expand into new areas of wellness, we plan to launch the Envision platform for the ophthalmology market during the first half of 2023, followed by the second generation of our hands-free platform for face treatments during the latter half of the year," said Dr.
Fourth Quarter 2022 Financial Results
Total revenues for the fourth quarter of 2022 reached
"We are proud to report another record quarter and year for total revenue, while again maintaining the target gross margin range of over
"I am very pleased that as a result, approximately
GAAP gross margin for the fourth quarter of 2022 was
GAAP operating margin for the fourth quarter of 2022 was
Full Year 2022 Financial Results
Total revenues for 2022 were
GAAP gross margin for 2022 was
GAAP operating margin for 2022 was
As of
2023 Financial Outlook
Management provided an outlook for the full year of 2023 ending
- Revenue between
and$525 million $530 million - *Non-GAAP gross margin between
83% and85% - *Non-GAAP income from operations between
and$236 million $238 million - *Non-GAAP earnings per diluted share between
and$2.58 $2.60
This outlook is not a guarantee of future performance and stockholders should not rely on such forward-looking statements. See "Forward-Looking Statements" for additional information.
*Please refer to "Use of Non-GAAP Financial Measures" below for important information about non-GAAP financial measures. Non-GAAP financial results exclude share-based compensation and certain tax adjustments. The Company applied the provisions of the amendment to the Investment Law to its exempt profits accrued prior to 2020 and made a one-time payment of
Use of Non-GAAP Financial Measures
In addition to
Conference Call Information
Mr. Moshe Mizrahy, Chairman and Chief Executive Officer, Dr.
The Company encourages participants to pre-register for the conference call using the following link:
https://dpregister.com/sreg/10174372/f5819ac374
Callers will receive a unique dial-in number upon registration, which enables immediate access to the call. Participants may pre-register at any time, including up to and after the call start time.
For callers who opt out of pre-registration, please dial one of the following teleconferencing numbers. Please begin by placing your call 10 minutes before the conference call commences. If you are unable to connect using the toll-free number, please try the international dial-in number.
International Dial-in Number: 1-412-317-5736
Webcast URL: https://event.choruscall.com/mediaframe/webcast.html?webcastid=JnMDK7VQ
At:
3:30 p.m. Israel Time
The conference call will also be webcast live from a link on
Replay Pin Number: 3700075
To access the replay using an international dial-in number, please select the link below:
https://services.choruscall.com/ccforms/replay.html
A replay of the conference call will also be available for 90 days on
About
Forward-Looking Statements
The information in this press release includes forward-looking statements within the meaning of the federal securities laws. These statements generally relate to future events or
Company Contact: Chief Financial Officer Phone: (949) 305-0108 Email: Yair.Malca@inmodemd.com | Investor Relations Contact: Phone: (917) 607-8654 Email: ir@inmodemd.com |
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(
(Unaudited)
Three months ended | Year Ended | |||
2022 | 2021 | 2022 | 2021 | |
REVENUES | 133,571 | 110,540 | 454,271 | 357,565 |
COST OF REVENUES | 21,002 | 16,847 | 73,485 | 53,592 |
GROSS PROFIT | 112,569 | 93,693 | 380,786 | 303,973 |
OPERATING EXPENSES: | ||||
Research and development | 3,261 | 2,528 | 12,425 | 9,532 |
Sales and marketing | 47,012 | 35,286 | 160,576 | 119,353 |
General and administrative | 2,398 | 2,527 | 9,931 | 8,411 |
Other Income | - | (800) | - | (800) |
TOTAL OPERATING EXPENSES | 52,671 | 39,541 | 182,932 | 136,496 |
INCOME FROM OPERATIONS | 59,898 | 54,152 | 197,854 | 167,477 |
Finance income, net | 3,962 | 118 | 3,612 | 525 |
INCOME BEFORE TAXES | 63,860 | 54,270 | 201,466 | 168,002 |
INCOME TAXES | 26,152 | 1,585 | 39,946 | 2,928 |
NET INCOME | 37,708 | 52,685 | 161,520 | 165,074 |
Less: net income attributable to non-controlling interests | - | - | - | (103) |
NET INCOME ATTRIBUTABLE TO INMODE LTD | 37,708 | 52,685 | 161,520 | 164,971 |
NET INCOME PER SHARE: | ||||
Basic | 0.46 | 0.63 | 1.96 | 2.03 |
Diluted | 0.44 | 0.61 | 1.89 | 1.92 |
WEIGHTED AVERAGE NUMBER OF SHARES | ||||
Basic | 82,449 | 83,234 | 82,482 | 81,445 |
Diluted | 85,288 | 86,384 | 85,404 | 86,017 |
CONDENSED CONSOLIDATED BALANCE SHEETS
(
(Unaudited)
2022 | 2021 | |
Assets | ||
CURRENT ASSETS: | ||
Cash and cash equivalents | 97,540 | 68,136 |
Marketable securities (amortized cost of | 374,589 | 294,530 |
Short-term bank deposits | 75,254 | 53,248 |
Accounts receivable, net of allowance for credit losses of | 26,997 | 20,236 |
Other receivables | 15,094 | 12,938 |
Inventories | 39,897 | 21,026 |
TOTAL CURRENT ASSETS | 629,371 | 470,114 |
NON-CURRENT ASSETS: | ||
Accounts receivable net of allowance for credit losses of | 3,973 | 768 |
Deferred income tax asset, net | 3,094 | 1,334 |
Operating lease right-of-use assets | 5,073 | 4,321 |
Property and equipment, net | 2,298 | 1,404 |
Other investments | 600 | 600 |
TOTAL NON-CURRENT ASSETS | 15,038 | 8,427 |
TOTAL ASSETS | 644,409 | 478,541 |
Liabilities and shareholders' equity | ||
CURRENT LIABILITIES: | ||
Accounts payable | 16,242 | 8,779 |
Contract liabilities | 13,798 | 13,805 |
Other liabilities | 51,980 | 29,266 |
TOTAL CURRENT LIABILITIES | 82,020 | 51,850 |
NON-CURRENT LIABILITIES: | ||
Contract liabilities | 3,959 | 2,751 |
Other liabilities | 303 | 4,831 |
Operating lease liabilities | 3,509 | 3,307 |
TOTAL NON-CURRENT LIABILITIES | 7,771 | 10,889 |
TOTAL LIABILITIES | 89,791 | 62,739 |
TOTAL SHAREHOLDERS' EQUITY | 554,618 | 415,802 |
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | 644,409 | 478,541 |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(
(Unaudited)
Three months ended | Year Ended | ||||
2022 | 2021 | 2022 | 2021 | ||
CASH FLOWS FROM OPERATING ACTIVITIES: | |||||
Net income | 37,708 | 52,685 | 161,520 | 165,074 | |
Adjustments required to reconcile net income to net cash provided by | |||||
Depreciation and amortization | 218 | 139 | 680 | 517 | |
Share-based compensation expenses | 7,148 | 3,124 | 24,452 | 11,962 | |
Change in allowance for credit losses of trade receivable | 47 | 141 | 449 | 516 | |
Loss on marketable securities, net | 22 | 142 | 71 | 175 | |
Finance expenses (income), net | (2,737) | (375) | (1,210) | 1,223 | |
Deferred income taxes, net | (72) | (379) | 84 | (770) | |
Changes in operating assets and liabilities: | |||||
Decrease (increase) in accounts receivable | 805 | 1,934 | (10,415) | (10,544) | |
Increase in other receivables | (1,081) | (1,982) | (1,787) | (6,400) | |
Increase in inventories | (4,087) | (1,848) | (18,871) | (6,043) | |
Increase (decrease) in accounts payable | 2,946 | (105) | 7,463 | 2,369 | |
Increase (decrease) in other liabilities | 14,575 | (2,056) | 17,941 | 14,138 | |
Increase in contract liabilities | 1,660 | 1,473 | 1,201 | 2,668 | |
Net cash provided by operating activities | 57,152 | 52,893 | 181,578 | 174,885 | |
CASH FLOWS FROM INVESTING ACTIVITIES: | |||||
Investment in short-term deposits | - | (7,000) | (93,701) | (73,090) | |
Proceeds from short-term deposits | - | 7,000 | 73,090 | 69,180 | |
Purchase of fixed assets | (328) | (182) | (1,575) | (939) | |
Purchase of marketable securities | (70,944) | (70,560) | (168,680) | (273,834) | |
Proceeds from sale of marketable securities | - | 33,785 | 2,303 | 93,652 | |
Proceeds from maturity of marketable securities | 32,997 | 6,150 | 79,089 | 24,925 | |
Net cash used in investing activities | (38,275) | (30,807) | (109,474) | (160,106) | |
CASH FLOWS FROM FINANCING ACTIVITIES: | |||||
Repurchase of ordinary shares | - | (23,444) | (42,637) | (35,365) | |
Exercise of options |
637 | 540 |
1,552 | 20,343 | |
Net cash provided by (used in) financing activities | 637 | (22,904) | (41,085) | (15,022) | |
EFFECT OF EXCHANGE RATE CHANGES ON CASH | 978 | 26 | (1,615) | (559) | |
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 20,492 | (792) | 29,404 | (802) | |
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD | 77,048 | 68,928 | 68,136 | 68,938 | |
CASH AND CASH EQUIVALENTS AT END OF PERIOD | 97,540 | 68,136 | 97,540 | 68,136 |
CONDENSED CONSOLIDATED FINANCIAL HIGHLIGHTS
(
(Unaudited)
Three months ended | Year Ended | ||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||
Revenues by Category: | |||||||||||
Capital Equipment revenues - | 80,352 | 60 % | 66,810 | 60 % | 260,992 | 58 % | 211,424 | 59 % | |||
Capital Equipment revenues - International | 36,094 | 27 % | 31,785 | 29 % | 133,220 | 29 % | 107,815 | 30 % | |||
Total Capital Equipment revenues | 116,446 | 87 % | 98,595 | 89 % | 394,212 | 87 % | 319,239 | 89 % | |||
Consumables and service revenues | 17,125 | 13 % | 11,945 | 11 % | 60,059 | 13 % | 38,326 | 11 % | |||
Total Net Revenue | 133,571 | 100 % | 110,540 | 100 % | 454,271 | 100 % | 357,565 | 100 % | |||
Three months ended | Year Ended | |||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||
% | % | % | % | |||||||||
United | International | Total | United | International | Total | United | International | Total | United | International | Total | |
Revenues by Technology: | ||||||||||||
Minimally Invasive | 86 | 76 | 83 | 74 | 70 | 73 | 85 | 74 | 81 | 71 | 73 | 72 |
Hands-Free | 11 | 4 | 9 | 23 | 6 | 17 | 12 | 6 | 10 | 27 | 7 | 20 |
Non-Invasive | 3 | 20 | 8 | 3 | 24 | 10 | 3 | 20 | 9 | 2 | 20 | 8 |
100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
RECONCILIATION OF GAAP CONDENSED CONSOLIDATED STATEMENTS OF
INCOME TO NON-GAAP CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(
(Unaudited)
Three months ended | Three months ended | |||||||
GAAP |
Share Based |
Undistributed Exempt Income |
Non-GAAP |
GAAP |
Share Based |
Other Income Related to IP Transactions |
Non-GAAP | |
REVENUES | 133,571 | - | - | 133,571 | 110,540 | - | - | 110,540 |
COST OF REVENUES | 21,002 | (553) | - | 20,449 | 16,847 | (304) | - | 16,543 |
GROSS PROFIT | 112,569 | 553 | - | 113,122 | 93,693 | 304 | - | 93,997 |
OPERATING EXPENSES: | ||||||||
Research and development | 3,261 | (918) | - | 2,343 | 2,528 | (442) | - | 2,086 |
Sales and marketing | 47,012 | (5,069) | - | 41,943 | 35,286 | (2,120) | - | 33,166 |
General and administrative | 2,398 | (608) | - | 1,790 | 2,527 | (258) | - | 2,269 |
Other Income | - | - | - | - | (800) | - | 800 | - |
TOTAL OPERATING | 52,671 | (6,595) | - | 46,076 | 39,541 | (2,820) | 800 | 37,521 |
INCOME FROM OPERATIONS | 59,898 | 7,148 | - | 67,046 | 54,152 | 3,124 | (800) | 56,476 |
Finance income, net | 3,962 | - | - | 3,962 | 118 | - | 118 | |
INCOME BEFORE TAXES | 63,860 | 7,148 | - | 71,008 | 54,270 | 3,124 | (800) | 56,594 |
INCOME TAXES | 26,152 | - | (21,514) | 4,638 | 1,585 | (184) | 1,401 | |
NET INCOME | 37,708 | 7,148 | 21,514 | 66,370 | 52,685 | 3,124 | (616) | 55,193 |
NET INCOME PER SHARE: | ||||||||
Basic | 0.46 | 0.80 | 0.63 | 0.66 | ||||
Diluted | 0.44 | 0.78 | 0.61 | 0.64 | ||||
WEIGHTED AVERAGE NUMBER OF | ||||||||
Basic | 82,449 | 82,449 | 83,234 | 83,234 | ||||
Diluted | 85,288 | 85,515 | 86,384 | 86,519 |
RECONCILIATION OF GAAP CONDENSED CONSOLIDATED STATEMENTS OF
INCOME TO NON-GAAP CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(
(Unaudited)
Year Ended | Year Ended | |||||||
GAAP | Share Based | Undistributed Exempt Income | Non-GAAP | GAAP | Share Based |
Other Income Related to IP Transactions | Non-GAAP | |
REVENUES | 454,271 | - | - | 454,271 | 357,565 | - | - | 357,565 |
COST OF REVENUES | 73,485 | (1,917) | - | 71,568 | 53,592 | (1,108) | - | 52,484 |
GROSS PROFIT | 380,786 | 1,917 | - | 382,703 | 303,973 | 1,108 | 305,081 | |
OPERATING EXPENSES: | ||||||||
Research and development | 12,425 | (3,166) | - | 9,259 | 9,532 | (1,554) | - |
7,978 |
Sales and marketing | 160,576 | (17,302) | - | 143,274 | 119,353 | (8,274) | - | 111,079 |
General and administrative | 9,931 | (2,067) | - | 7,864 | 8,411 | (1,026) | - |
7,385 |
Other Income | - | - | - | - | (800) | - | 800 | - |
TOTAL OPERATING | 182,932 | (22,535) | - | 160,397 | 136,496 | (10,854) | 800 | 126,442 |
INCOME FROM OPERATIONS | 197,854 | 24,452 | - | 222,306 | 167,477 | 11,962 | (800) | 178,639 |
Finance income, net | 3,612 | - | - | 3,612 | 525 | - | - | 525 |
INCOME BEFORE TAXES | 201,466 | 24,452 | - | 225,918 | 168,002 | 11,962 | (800) | 179,164 |
INCOME TAXES (TAX BENEFIT) | 39,946 | - | (21,514) | 18,432 | 2,928 | - | (184) | 2,744 |
NET INCOME | 161,520 | 24,452 | 21,514 | 207,486 | 165,074 | 11,962 | (616) | 176,420 |
Less: net income attributable to non-controlling interests | - | - | - | - | (103) | - | - | (103) |
NET INCOME ATTRIBUTABLE TO INMODE LTD. | 161,520 | 24,452 | 21,514 | 207,486 | 164,971 | 11,962 | (616) | 176,317 |
NET INCOME PER | ||||||||
Basic | 1.96 | 2.52 | 2.03 | 2.16 | ||||
Diluted | 1.89 | 2.42 | 1.92 | 2.05 | ||||
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF NET INCOME PER SHARE (in thousands) | ||||||||
Basic | 82,482 | 82,482 | 81,445 | 81,445 | ||||
Diluted | 85,404 | 85,628 | 86,017 | 86,192 |
View original content:https://www.prnewswire.com/news-releases/inmode-reports-fourth-quarter-and-full-year-2022-financial-results-record-quarterly-revenue-of-133-6m-represents-21-year-over-year-growth-301745737.html
SOURCE
FAQ
What were InMode's Q4 2022 financial results?
How did InMode perform in 2022 compared to 2021?
What is InMode's earnings per share for Q4 2022?